CDCP1 and cancer: Interpretation of the effects of anti-CD318 could be confounded by the potential for nonspecific triggering of antibody-dependent cellular cytotoxicity through opsonization of cancer cells by anti-CD318, in addition to interruption of the ability of CD318 to engage CD6.